<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/62B693D8-12F4-4EEE-A622-010188252868"><gtr:id>62B693D8-12F4-4EEE-A622-010188252868</gtr:id><gtr:name>North Bristol NHS Trust</gtr:name><gtr:address><gtr:line1>Trust Headquarters</gtr:line1><gtr:line2>Frenchay Hospital</gtr:line2><gtr:line3>Beckspool Road, Frenchay</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS16 1JE</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Inst of Molecular &amp; Cellular Biology</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/62B693D8-12F4-4EEE-A622-010188252868"><gtr:id>62B693D8-12F4-4EEE-A622-010188252868</gtr:id><gtr:name>North Bristol NHS Trust</gtr:name><gtr:address><gtr:line1>Trust Headquarters</gtr:line1><gtr:line2>Frenchay Hospital</gtr:line2><gtr:line3>Beckspool Road, Frenchay</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS16 1JE</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FAB06145-89EB-432F-A39D-75803C4D7340"><gtr:id>FAB06145-89EB-432F-A39D-75803C4D7340</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EBA26F39-5359-49BF-BD3D-A4FB6C93AA76"><gtr:id>EBA26F39-5359-49BF-BD3D-A4FB6C93AA76</gtr:id><gtr:firstName>Nigel</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Hooper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0802189"><gtr:id>7DF5E6A4-D65F-4DC9-9854-9066173D546F</gtr:id><gtr:title>Alzheimers and prion diseases: cellular and genetic mechanisms of neurodegeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802189</gtr:grantReference><gtr:abstractText>Alzheimers disease is the commonest form of dementia that affects a large proportion of the elderly population of the UK. Many other people are affected through knowing a family member or friend who has this debilitating disease. Prion diseases, such as Creutzfeldt-Jakob disease (CJD), are much rarer but have received much attention in recent years because of the still unknown number of people in the UK infected following the epidemic of bovine spongiform encephalopathy (BSE) (mad cow disease). Both these brain diseases are fatal and, as yet, there are no cures for either disease. We have noticed similarities in the way that brain cells regulate the processing of key proteins that cause Alzheimers and prion diseases. The aim of this proposal is to investigate these processes in cells and animals, as well as in post-mortem brain tissue from Alzheimers patients. The results from our work will help us understand how these diseases develop and may aid in the identification of new treatments.</gtr:abstractText><gtr:technicalSummary>Alzheimers disease (AD) is the major neurodegenerative disease of the aging brain that is extremely complex and poorly understood but which poses an ever-expanding burden on the Health Service and society in an aging population. By contrast the prion diseases, such as Creutzfeldt-Jakob disease, are relatively rare but have received much attention in recent years because of the potential number of individuals in the UK affected following the epidemic of bovine spongiform encephalopathy. Our working hypothesis is that common molecular and cellular mechanistic features exist between AD and prion diseases. AD is characterised by the deposition in the brain of amyloid-beta peptides that are derived by proteolytic cleavage of the amyloid precursor protein (APP), while prion diseases are characterised by the conformational conversion of the cellular form of the prion protein (PrPC) to the pathogenic form, PrPSc. The overall aim of this proposal is to elucidate further and compare the cellular and genetic regulation of the proteolytic mechanisms and protein-protein interactions that are involved in the normal and pathogenic processing and functions of APP and PrPC. The specific objectives are: 
(a) to determine the cellular mechanism by which PrPC inhibits the rate limiting cleavage of APP by the beta-secretase BACE1, and by what mechanism other interacting proteins (that we have identified from the BACE1 and APP interactomes) modulate the cleavage of APP. In addition, we will examine whether key BACE1 and APP interacting proteins are altered in AD and aging, establish if PrPC modulates the gamma-secretase cleavage of APP and determine the mechanism by which the modulation of neurotransmitter receptor signalling increases the alpha-secretase cleavage of APP;
(b) to determine the roles of PrPC endoproteolysis and interacting proteins (some of which are shared with APP) on PrPC function and conversion to PrPSc, and whether PrPC protects against cognitive dysfunction in a mouse model of AD. In addition, we will assess whether localisation of PrPC in different membrane domains modulates its protein interactome;
(c) to investigate the mechanism by which the intracellular domain of APP and histone deacetylase inhibitors may regulate expression of a subset of AD-related genes, especially neprilysin, and to examine if there are global changes in neuronal chromatin in AD and prion disease.
Appreciating the intricacy of the cellular systems will not only advance our understanding of these neurodegenerative disorders but will also help with designing therapeutic interventions as precisely as possible to avoid unintended consequences.</gtr:technicalSummary><gtr:fund><gtr:end>2014-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1269522</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>North Bristol NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Leeds-Bristol</gtr:description><gtr:id>D1F30BDB-BDFD-4ABF-9950-95494B83BFA3</gtr:id><gtr:impact>Outputs listed elsewhere</gtr:impact><gtr:partnerContribution>Colleagues in Bristol have supplied human brain material and associated data</gtr:partnerContribution><gtr:piContribution>My research team has provided experimental data</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Leeds-Edinburgh</gtr:description><gtr:id>93F742B0-4928-46A5-B6E2-E9C3794878CE</gtr:id><gtr:impact>Pilot grant from the Alzheimer's Research Trust and a submitted publication.
Publication in PLOS ONE</gtr:impact><gtr:partnerContribution>Expertise in animal models</gtr:partnerContribution><gtr:piContribution>Intellectual input into the design of experiments and analysis of results based on work originating from Leeds.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Leeds-Edinburgh</gtr:description><gtr:id>9E1F36A1-AE73-43EB-9009-37CCEBBBA761</gtr:id><gtr:impact>Pilot grant awarded by the Alzheimer's Research Trust to establish a new mouse model for Alzheimer's disease</gtr:impact><gtr:partnerContribution>Initial data has been generated which is the subject of a submitted publication.</gtr:partnerContribution><gtr:piContribution>Ongoing intellectual input to the design of experiments and writing of grant applications based on findings arising from research in Leeds</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dementia website</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A4470CD9-5E82-4122-8B70-32AC280D6B48</gtr:id><gtr:impact>.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.fbs.leeds.ac.uk/blogs/dementia/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parliament (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C5AC80D6-BCE6-4FEB-848E-17D2A68DCF46</gtr:id><gtr:impact>Approx 25 members of parliament and public attended, sparked questions.

Too ealry to tell</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1947D363-7FB8-47AD-829C-F291A7CD6319</gtr:id><gtr:impact>50 members of the public/health profession attended

.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit, Huddersfield</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>78FEE862-401F-4921-9850-971F6178CF00</gtr:id><gtr:impact>30 pupils attended

.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Cell Biology or Neurons and Glia - dinner discussion</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>93C8F076-9605-4517-ABCC-AF60AA0D6D1E</gtr:id><gtr:impact>Discussion paper produced by MRC

.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interviews (2013)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>71CE36B7-14DA-4B20-81F3-C961F67057B9</gtr:id><gtr:impact>Invited to talk about research on BBC Radio Leeds, BBC Radio 4 Today programme, radio programme for Ireland.

Increased awareness of our research on dementia</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alumni (Leeds)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ED020289-579F-45EE-9D79-51CE3DB7CBA3</gtr:id><gtr:impact>Several alumni attended of which some have decided to donate funds for our research

Funding to support summer placement students and a PhD student secured</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit, Huddersfield</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1249944C-7B5A-4C2B-8AD7-556D591AB812</gtr:id><gtr:impact>20 sixth form students attended

.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Breakfast TV</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CED94B09-04CC-46A1-A048-33A680F897C8</gtr:id><gtr:impact>.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media (as a channel to the public)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A59DC899-0150-4218-BCBE-9FD5C61E157D</gtr:id><gtr:impact>Press releases issues by University, ARUK or MRC which was taken up by numerous agencies.

Increased awareness of and impact of our research. Invitations to speak on local and national radio.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Differential production of amyloid-beta from the APP isoforms</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-PhD2012-5</gtr:fundingRef><gtr:id>E39AAC97-A119-4FE7-9C13-54B16F204E70</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>244926</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigating the neurotoxic mechanisms of amyloid-? oligomers: role of the prion protein</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ART-PG2010-2</gtr:fundingRef><gtr:id>48540B3D-48F7-4BA4-B828-8C9E9A3E89EF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>327074</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A cell surface, lipid raft-based signaling complex links amyloid-? to tau via Fyn'</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-PG2013-12</gtr:fundingRef><gtr:id>EBFB4FFC-86C0-418D-AF7C-616FE28E335A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Dementia stratification workshop</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>63FB6990-DCC0-4A17-9320-2AA88E1A3655</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>TSB dementia stratification (London)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>14A72FE0-A30C-460B-B5E3-D5A5A22212EC</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Cell lines transfected with various constructs of the prion protein or amyloid precursor protein.</gtr:description><gtr:id>9227B349-D169-4C75-AD50-48FD2E3893BA</gtr:id><gtr:impact>Various publications resulting from use of cells</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transfected cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Various mammalian cell lines transfected with constructs of APP, PrP and other proteins involved in Alzheimer's disease.</gtr:description><gtr:id>9F8CEE7B-0A58-4277-BC44-BADC23F463C4</gtr:id><gtr:impact>These cell lines have contributed significantly to publications arising from our research group and that of others.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transfected cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>PrP null mice have been crossed with the J20 mouse model of Alzheimer's disease</gtr:description><gtr:id>65F6A32D-8B3B-40E6-9DD3-D5D4BAC645F1</gtr:id><gtr:impact>A publication describing the effect of deletion of PrP on APP processing.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PrP null - J20 mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Crossing of PrP null mice with I5 mice wild type for human APP</gtr:description><gtr:id>34980B7C-2F00-43A1-8984-5B2A1D5D8C2B</gtr:id><gtr:impact>.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PrP null - I5 mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>PrP null mice have been crossed with the J20 Alzheimer's model mouse.</gtr:description><gtr:id>62A78A08-9DC0-4560-B2AC-89A9D5C57AC3</gtr:id><gtr:impact>A publication reporting the results of depletion of PrP on APP processing.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PrP null J20 mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F217BE8-78DD-4B64-ADB6-B8B9365C46E0"><gtr:id>9F217BE8-78DD-4B64-ADB6-B8B9365C46E0</gtr:id><gtr:title>Nuclear signalling by membrane protein intracellular domains: the AICD enigma.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7dee22bbeafb76f482a8fee3018e19c9"><gtr:id>7dee22bbeafb76f482a8fee3018e19c9</gtr:id><gtr:otherNames>Beckett C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CE70FED-57DE-414B-8BB1-8B50FC235A8C"><gtr:id>5CE70FED-57DE-414B-8BB1-8B50FC235A8C</gtr:id><gtr:title>Prion protein-mediated toxicity of amyloid-? oligomers requires lipid rafts and the transmembrane LRP1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8d287505d2b132abef352149f8c0ea7"><gtr:id>d8d287505d2b132abef352149f8c0ea7</gtr:id><gtr:otherNames>Rushworth JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/323D128D-601E-4E30-BE28-88CFCAD99A00"><gtr:id>323D128D-601E-4E30-BE28-88CFCAD99A00</gtr:id><gtr:title>Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C0820CFA-9307-4EC5-9B93-0F5995EF8672"><gtr:id>C0820CFA-9307-4EC5-9B93-0F5995EF8672</gtr:id><gtr:title>Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/82ca7ca047e13bb8f91e257fe569592d"><gtr:id>82ca7ca047e13bb8f91e257fe569592d</gtr:id><gtr:otherNames>Clarke NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F332168-5BB0-4CE4-A073-94FA664014CC"><gtr:id>7F332168-5BB0-4CE4-A073-94FA664014CC</gtr:id><gtr:title>Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EE441B67-5F87-4F7B-8903-6E38E1916547"><gtr:id>EE441B67-5F87-4F7B-8903-6E38E1916547</gtr:id><gtr:title>Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-? levels and Braak stage.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18e48e96d9bf224f83e6404d9aaaff3f"><gtr:id>18e48e96d9bf224f83e6404d9aaaff3f</gtr:id><gtr:otherNames>Whitehouse IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AD5E2CE-B2E3-45B8-85D1-F4DB2B18F146"><gtr:id>0AD5E2CE-B2E3-45B8-85D1-F4DB2B18F146</gtr:id><gtr:title>Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dea58225bb19e3ca036aecf0e8d76496"><gtr:id>dea58225bb19e3ca036aecf0e8d76496</gtr:id><gtr:otherNames>Griffiths HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31C54699-7C9D-4BD6-BBA5-9F76A1EC3CBD"><gtr:id>31C54699-7C9D-4BD6-BBA5-9F76A1EC3CBD</gtr:id><gtr:title>Lipid rafts: linking prion protein to zinc transport and amyloid-? toxicity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/541d949c24596c6bec271f38c5bec152"><gtr:id>541d949c24596c6bec271f38c5bec152</gtr:id><gtr:otherNames>Watt NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2296-634X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92334DD6-C868-4291-9B49-66B63361F2AF"><gtr:id>92334DD6-C868-4291-9B49-66B63361F2AF</gtr:id><gtr:title>The role of zinc in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>International journal of Alzheimer's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/541d949c24596c6bec271f38c5bec152"><gtr:id>541d949c24596c6bec271f38c5bec152</gtr:id><gtr:otherNames>Watt NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77B9100C-236B-41E1-906A-B1FBECFD29D7"><gtr:id>77B9100C-236B-41E1-906A-B1FBECFD29D7</gtr:id><gtr:title>Prion protein facilitates uptake of zinc into neuronal cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/541d949c24596c6bec271f38c5bec152"><gtr:id>541d949c24596c6bec271f38c5bec152</gtr:id><gtr:otherNames>Watt NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A0A3F27-ED1F-42F8-88B8-B42780D9ED44"><gtr:id>4A0A3F27-ED1F-42F8-88B8-B42780D9ED44</gtr:id><gtr:title>Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B4816EC-B4C8-4A1A-8CBF-8D259575AC78"><gtr:id>0B4816EC-B4C8-4A1A-8CBF-8D259575AC78</gtr:id><gtr:title>The amyloid precursor protein: a biochemical enigma in brain development, function and disease.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D618C141-5BF5-4ED5-A260-FD5558193C17"><gtr:id>D618C141-5BF5-4ED5-A260-FD5558193C17</gtr:id><gtr:title>The role of lipid rafts in prion protein biology.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience (Landmark edition)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0eb1f7a21303a5ebf079bad40b415e5a"><gtr:id>0eb1f7a21303a5ebf079bad40b415e5a</gtr:id><gtr:otherNames>Lewis V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1093-4715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25F137D4-6547-46F4-9148-4C06253D82EC"><gtr:id>25F137D4-6547-46F4-9148-4C06253D82EC</gtr:id><gtr:title>New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.</gtr:title><gtr:parentPublicationTitle>Neurochemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-3190</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43968A7C-E51E-4CAD-AD46-20B9F1A550CE"><gtr:id>43968A7C-E51E-4CAD-AD46-20B9F1A550CE</gtr:id><gtr:title>BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6b4ff42a2d68abb2814b8deb6088a28b"><gtr:id>6b4ff42a2d68abb2814b8deb6088a28b</gtr:id><gtr:otherNames>Glennon EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D75968E9-2383-47D2-BBAB-1FFDC42588B2"><gtr:id>D75968E9-2383-47D2-BBAB-1FFDC42588B2</gtr:id><gtr:title>The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e800021f1d2d46d8c34c5b180495b4e"><gtr:id>1e800021f1d2d46d8c34c5b180495b4e</gtr:id><gtr:otherNames>Hong Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9B190C34-0BF5-4776-9EA1-4EC53CBDEFFC"><gtr:id>9B190C34-0BF5-4776-9EA1-4EC53CBDEFFC</gtr:id><gtr:title>Effect of sodium valproate administration on brain neprilysin expression and memory in rats.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d44e15c61465b5e28d55e404cebd2b6"><gtr:id>0d44e15c61465b5e28d55e404cebd2b6</gtr:id><gtr:otherNames>Nalivaeva NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/563618B4-C0F6-4D79-98D7-3064461B77E0"><gtr:id>563618B4-C0F6-4D79-98D7-3064461B77E0</gtr:id><gtr:title>Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0eb1f7a21303a5ebf079bad40b415e5a"><gtr:id>0eb1f7a21303a5ebf079bad40b415e5a</gtr:id><gtr:otherNames>Lewis V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF124101-1273-4031-82B5-EC3A1EBA1692"><gtr:id>CF124101-1273-4031-82B5-EC3A1EBA1692</gtr:id><gtr:title>Lipid Rafts: Linking Alzheimer's Amyloid-? Production, Aggregation, and Toxicity at Neuronal Membranes.</gtr:title><gtr:parentPublicationTitle>International journal of Alzheimer's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8d287505d2b132abef352149f8c0ea7"><gtr:id>d8d287505d2b132abef352149f8c0ea7</gtr:id><gtr:otherNames>Rushworth JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61E784B5-8034-4EEA-9D98-5D34B8570847"><gtr:id>61E784B5-8034-4EEA-9D98-5D34B8570847</gtr:id><gtr:title>Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18e48e96d9bf224f83e6404d9aaaff3f"><gtr:id>18e48e96d9bf224f83e6404d9aaaff3f</gtr:id><gtr:otherNames>Whitehouse IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB2C4C68-1656-4854-B0FB-D3E1500ECAF8"><gtr:id>EB2C4C68-1656-4854-B0FB-D3E1500ECAF8</gtr:id><gtr:title>Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0cfeffc5253202ae9e868dd20253f335"><gtr:id>0cfeffc5253202ae9e868dd20253f335</gtr:id><gtr:otherNames>Vardy ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/464015EB-BDA3-4E11-B705-6DFC4962D72C"><gtr:id>464015EB-BDA3-4E11-B705-6DFC4962D72C</gtr:id><gtr:title>Neuronal zinc regulation and the prion protein.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/541d949c24596c6bec271f38c5bec152"><gtr:id>541d949c24596c6bec271f38c5bec152</gtr:id><gtr:otherNames>Watt NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/609AD91F-9419-44F7-AD8F-DC693F252435"><gtr:id>609AD91F-9419-44F7-AD8F-DC693F252435</gtr:id><gtr:title>Characterisation of acetylcholinesterase release from neuronal cells.</gtr:title><gtr:parentPublicationTitle>Chemico-biological interactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/227ad5e09a226ffaf51c9ba49499263a"><gtr:id>227ad5e09a226ffaf51c9ba49499263a</gtr:id><gtr:otherNames>Hicks DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-2797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87ACB9A6-A6F8-4598-A430-67389A2CC723"><gtr:id>87ACB9A6-A6F8-4598-A430-67389A2CC723</gtr:id><gtr:title>The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/227ad5e09a226ffaf51c9ba49499263a"><gtr:id>227ad5e09a226ffaf51c9ba49499263a</gtr:id><gtr:otherNames>Hicks DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51A728B9-B3AC-4A04-8C6E-CF23632781A6"><gtr:id>51A728B9-B3AC-4A04-8C6E-CF23632781A6</gtr:id><gtr:title>The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5dd409cf763310de09deaf372d1118b"><gtr:id>a5dd409cf763310de09deaf372d1118b</gtr:id><gtr:otherNames>Belyaev ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E88C13EC-37E0-4B09-A793-0E105F7C1D10"><gtr:id>E88C13EC-37E0-4B09-A793-0E105F7C1D10</gtr:id><gtr:title>Prion protein &amp;quot;gamma-cleavage&amp;quot;: characterizing a novel endoproteolytic processing event.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0eb1f7a21303a5ebf079bad40b415e5a"><gtr:id>0eb1f7a21303a5ebf079bad40b415e5a</gtr:id><gtr:otherNames>Lewis V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/45D8BC14-B6C9-45C6-B269-8B78D0408BEC"><gtr:id>45D8BC14-B6C9-45C6-B269-8B78D0408BEC</gtr:id><gtr:title>Regulation of amyloid-? production by the prion protein.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dea58225bb19e3ca036aecf0e8d76496"><gtr:id>dea58225bb19e3ca036aecf0e8d76496</gtr:id><gtr:otherNames>Griffiths HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/041A99B3-56B0-41A7-B4FC-D43197B3F7B7"><gtr:id>041A99B3-56B0-41A7-B4FC-D43197B3F7B7</gtr:id><gtr:title>Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-? or Pathologic Phenotype.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18e48e96d9bf224f83e6404d9aaaff3f"><gtr:id>18e48e96d9bf224f83e6404d9aaaff3f</gtr:id><gtr:otherNames>Whitehouse IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802189</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>